In the race for a coronavirus vaccine, first doesn’t mean best
A vaccine is seen as the Holy Grail of coronavirus research, but the first vaccine out to market may not be the one you want to take.
Our shared future depends on innovating in the fields of science, business, healthcare and technology. Learn more about Israeli leaders in disruptive solutions, cutting-edge research, and other emerging trends that will positively impact our world.
A vaccine is seen as the Holy Grail of coronavirus research, but the first vaccine out to market may not be the one you want to take.
Zeekit helps brands show shoppers how an item looks on 16 diverse models, at a time when models can’t come in for photoshoots.
Genome sequencing shows that majority of infected Israelis had a particular strain of the coronavirus that originated in the US.
As part of their post-Covid economic strategy, Florida, Oklahoma, Texas and Arizona are stepping up cooperation with Israeli companies.
Unlike chlorine bleach and similar surface disinfecting products, the new substances target the virus infection mechanism and remain active longer.
‘When I arrived at the trauma room, I saw a man with an iron rod in his head – literally crossing his head from side to side,’ says doctor from Hadassah Medical Center.
Israeli-led study reveals harmful immune cells invade the lungs of patients severely affected by Covid-19, crowding out helpful immune cells.
Imaging method could help doctors select the highest-quality sperm for injection into the egg, increasing IVF treatment’s chances of success.
For Skin Cancer Awareness Month, we take a look at significant research which could help doctors and scientists prevent melanoma, or help turn it into a curable disease.
The corona outbreak has forced us to embrace our future faster than we planned – both for good and for bad. Find out more in our webinar with two futurists.
FDA permits Israeli company’s AI technology to be used as adjunct in detection of findings associated with Covid-19 in CT scans involving the lungs.
Israeli trend predicters and futurists tell us what to expect in the post-Covid world, from how we will buy to how we will fly.
Regenerative medicine firm Pluristem gets €50 million venture debt loan, recently treated Covid-19 patients with its placenta-derived product.
‘I thought it might be helpful to try these things in parallel to regular medicine,’ says Barzilai Medical Center CEO and medical director.
Global survey of 4,039 coronavirus patients supports evidence of chemosensory function loss including perception of certain tactile sensations.